HV Capital is a Munich- and Berlin-based venture capital firm that supports founders in developing their internet companies. Since 2000 HV Capital, formerly HV Holtzbrinck Ventures, has invested in Internet and technology companies through various generations of funds and is one of the most successful and financially strongest early-stage and growth investors in Europe. HV Capital has already invested in around 200 companies, including Zalando, Delivery Hero, FlixMobility and SumUp. The total of all HV Funds amounts to €1.7 billion. The company supports startups with capital between €500,000 and €50 million. This makes HV Capital one of the few venture capitalists in Europe that can finance startups through all growth phases.

HV Capital

FoodLabs is a venture studio and investor for startups with solutions to feed ten billion people by 2050 in a sustainable and healthy way. Founded in 2016, the Berlin-based investor is one of Europe's leading venture firms for food & ag. It has supported over 20 mission-driven teams to launch their ideas and put great concepts into practice. The portfolio covers the entire value chain - from agtech, alternative protein sources, water supply, food security, vertical farming, to food waste and carbon reduction.

FoodLabs

TQ Ventures LLC is a venture capital firm led by Schuster Tanger and Andrew Marks based in New York City.  The firm seeks out extraordinary founders across the software complex in businesses with durable competitive advantages. We’re involved in primarily business-to-business (B2B) models, but also some business-to-consumer (B2C) models.  Across our more than 80 global investments, we believe the differentiated support and networks we provide our founders have fueled our track record and our reputation. Founded in 2018, TQ now has around $1 billion under management and is currently investing out of our third $500m fund.  The TQ Ventures investment philosophy:  The overarching ethos of TQ Ventures is: Backing founders building the future. we judge all startups by the same simple rubric:  · Do the founders demonstrate exceptional talent and vision? · Are they solving a problem or delivering an experience that provides substantial value to customers? · Are there enough customers to constitute a large market? · Is there a compelling go-to-market motion to effectively reach those customers? · If successful, will the company have high margins, low capital intensity, scalability with minimal friction and low incremental costs and, crucially, durable competitive advantages? · Are we investing at a valuation that, if the business succeeds, will deliver returns exceeding our fund’s committed capital net of dilution?  Bottom-up Approach versus Thematic or Vertical-Focused  Our investment firm looks for opportunities across a wide range of industries and sectors, with a bottom-up business-model-driven approach. Current investments cover industries including:  · Infrastructure · Artificial Intelligence/Machine Learning · Enterprise · Development Tools · Software as a Service (SaaS) · Consumer Tech · Fintech and Blockchain · Healthcare · Geography  While TQ is based in New York City, some of its team is in San Francisco. TQ has a strong presence in top American venture markets, such as the Bay Area and NYC, but also has invested prolifically in Europe, including CEE. Once in a while, TQ finds a business that fits its investment framework in an emerging market as well.  Our global reach helps TQ Ventures find the best possible businesses to invest with. TQ Ventures leadership team  The TQ Ventures team is led by Schuster Tanger and Andrew Marks, two NYC-based investors with backgrounds from some of the top investing firms globally. Schuster worked at Third Point (Dan Loeb) and Goldman Sachs (Special Situations Group with Josh Easterly), before breaking away to launch TQ Ventures in 2018. He was named in the 2013 Forbes 30 under 30.  Andrew was a managing director at Blue Ridge Capital and previously worked at Blackstone before launching TQ Ventures in 2018. Our team members include talented investment professionals Jana Iris (ex-Hashicorp), Alexis Vitenas (ex-sales), Elisabeth Rulke (Princeton physics), Finbarr Timbers (Midjourney, ex-DeepMind), Elliot Graebert (ex-Palantir) and Michael Kilberry (AI / ML Google).  TQ Venture success stories  With more than 80 portfolio companies under the TQ Ventures umbrella and our third investment fund well under way, TQ Ventures has a track record of successful partnerships. Recent TQ Venture partner companies include: · log10: An AI company based in San Francisco that offers large language model (LLMOps) support for machine learning applications. · nsave: A fintech company that brings secure banking to people from emerging economies. · Cleanlab: An AI firm that automates data science testing and repair to endeavor to make sure AI-derived data is error free. · Plenful: A healthcare software provider that makes pharmaceutical workflows more efficient using AI.  Partner with TQ Ventures  The team at TQ Ventures is always looking for emerging companies with a differentiated business model and an exciting outlook on the future. Our bottom-up generalist philosophy, enthusiasm for innovative businesses, and ability to help with B2B customer introductions make us the ideal investor for early-stage businesses on the rise.  To explore opportunities with T! Ventures LLC, please visit tqventures.com.  TQ Ventures FAQs  Who owns TQ Ventures? TQ Ventures is owned by partners Schuster Tanger and Andrew Marks. They co-founded the company in 2018 and now lead a team of investors overseeing 80 partner companies and over $1 Billion in investment funds.TQ is made up of external limited partners, but no external partners own any of the general partner.  What is TQ Ventures III? TQ Ventures III is the third vintage of TQ, a $500 million investment fund round complex operated by TQ Ventures. This portfolio took the overall funds managed by TQ Ventures to over $1 Billion. TQ Ventures III Early focuses on seed-stage companies while TQ Ventures III Growth focuses on Series B-stage companies.  What are the investment focus areas of TQ Ventures? While TQ Ventures is a generalist investment firm and operates in a wide spectrum of industry sectors and geographical locations, it does focus on early-stage investment, primarily seed through Series B. The firm believes in business-model-driven investments, with particular interest in durable competitive advantages.  What industries does TQ Ventures invest in? TQ Ventures is industry vertical agnostic. That means the investment firm invests in a wide range of industries, including fintech, healthcare, AI and machine learning, blockchain, crypto, and infrastructure.

TQ Ventures

OrganiGram is a producer and distributor of medical and recreational cannabis. They are dedicated to consistently providing clients with the highest grade medicine and service. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint.

OrganiGram

Calyx Bio-Ventures holds biotechnology assets. It owns REM technology platform, the rights to use the ACE System technology for gene therapy and transgenics, and a 29% interest in Agrisoma Biosciences, Inc.

Calyx Bio-Ventures

Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of their businesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.

Cherry Ventures

redalpine is the Swiss venture capital firm that empowers GameChangers. Founded in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management, the firm has backed some of Europe’s most disruptive software and science companies, including N26, Taxfix, Inkitt, 9fin, Carvolution, vivenu, and Infinite Roots. redalpine has over 95 companies in its portfolio and invests Europe-wide from its offices in Zurich and Berlin.

redalpine

Founded in March 2011, German Media Pool is Germany's leading independent media for equity fund combining television, out of home, print and radio. They have invested more than 175 million Euro in gross media volume in more than 50 investment rounds into 28 startups. They currently count 12 successful exits and 2 IPOs, with more to come.

German Media Pool

Navy Capital’s research-oriented, fundamentally-driven investment process focuses on identifying attractive opportunities within the legal cannabis space. Navy Capital seeks to find the best in class businesses within key verticals of the global cannabis industry. Those verticals include Consumer, Healthcare, Technology, Industrials, and Agriculture.

Navy Capital

SOJE Capital operates as an investment firm.

SOJE Capital

Casa Verde Capital is a venture capital firm specialized in seed investments. Casa Verde Capital (CVC) maintains a view that the cannabis industry will be among the most compelling investment themes of our generation. CVC is a venture capital firm focusing on the ancillary cannabis industry. The ancillary ecosystem is commonly referred to as “not touching the plant;'' this category includes, but is not limited to, agtech, health & wellness, financial services, technology, media, compliance and laboratory technology.

Casa Verde Capital

British American Tobacco manufactures tobacco products. They specialize in the consumer goods business. They sell vapor e-cigarettes, including heated tobacco and smokeless tobacco products. Their product materials include paper and filters for cigarettes, and they have a supply chain in consumer electronics and e-liquids.

British American Tobacco

Sanity Group

Sanity Group is a European cannabis company focusing on health, wellbeing, and scientific research. The company's mission is to improve people’s quality of life through the use of cannabinoids, thus developing consumer products based on non-psychoactive cannabinoids. It was founded in 2018 and is headquartered in Berlin, Germany.

Sanity Group is a Berlin-based cannabis company that aims to improve people's quality of life through the utilization of cannabinoids. The company operates in the medical, consumer health, and scientific sectors, focusing on pharmaceuticals, medical products, and consumer goods. Sanity Group encompasses various subsidiaries, including Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (finished pharmaceuticals), Belfry Medical (medical products and digital applications), VAAY (wellbeing), and This Place (natural cosmetics).

The Top Cannabis Firms In Germany In 2024

Successful closing of Series B Financing Round

Organigram takes minority stake in German cannabis firm Sanity Group with $21-million investment

Factsheets on cannabis legalization in Germany

Sanity Group: Unlocking the benefits of cannabinoids

Social and cultural shifts accompanied by changes in laws spark new opportunities

Cannabis

Organigram invests 14 million euros in German cannabis operator Sanity Group

Sanity Group is a Berlin-based cannabis company that aims to improve people's quality of life through the utilization of cannabinoids. The company operates in the medical, consumer health, and scientific sectors, focusing on pharmaceuticals, medical products, and consumer goods. Sanity Group encompasses various subsidiaries, including Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (finished pharmaceuticals), Belfry Medical (medical products and digital applications), VAAY (wellbeing), and This Place (natural cosmetics).
In September 2022, Sanity Group successfully closed a USD 37.6 million Series B financing round, marking Europe's largest cannabis investment round to date. This funding was led by BAT Group, with continued support from existing investors such as Redalpine and Casa Verde Capital, bringing the total funds raised by the company to over USD 100 million. The new investment will fuel Sanity Group's growth, enable European expansion, and strengthen research and development activities.
Near Frankfurt am Main, Sanity Group operates a production and processing facility for cannabis extracts. In June 2024, Organigram Holdings Inc., a Canadian cannabis producer, took a minority stake in Sanity Group through a USD 21 million investment, with the potential for an additional USD 4.5 million investment via an unsecured convertible note. This investment aims to help Organigram capitalize on the recent legalization of cannabis in Germany, where Sanity Group holds approximately 10% market share in the medical cannabis market.

Cresco Labs is a vertically integrated multistate cannabis operator with a focus on delivering consistent quality products across its portfolio of branded offerings. The company cultivates, processes, and distributes a diverse range of cannabis products, including flower, vapes, concentrates, edibles, and pre-rolls. Cresco Labs operates under multiple brands, such as Cresco, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's Edibles, and Remedi, catering to various consumer preferences and occasions.
Cresco's cultivation practices involve rigorous phenotype hunting and small-batch cultivation to ensure premium quality. Their products are meticulously hand-trimmed and expertly cared for throughout the process. The company's brand portfolio aims to provide consistent, reliable, and enjoyable cannabis experiences for consumers, whether they are familiar with the plant or new to it.
As of December 2023, Cresco Labs operated in numerous states across the US, with 21 production facilities and 49 dispensaries under the Sunnyside retail banner. The company has implemented operational changes to improve its environmental impact and formed partnerships, such as with Temple University, to explore the potential healing properties of cannabis.
In February 2023, Cresco Labs expanded its retail presence by opening a new Sunnyside dispensary in Daytona Beach, Florida, marking its 23rd location in the state and 58th nationwide. The company reported generating revenue of approximately USD 822 million for the full year 2021.

Cresco Labs

<div>
 
 TerrAscend is a leading North American cannabis operator with vertically integrated operations in California, Maryland, Michigan, New Jersey, and Pennsylvania, as well as retail operations in Canada. The company focuses on growing high-quality cannabis, promoting its health benefits, and offering a diverse range of products tailored to the needs of medical patients and adult-use consumers. TerrAscend utilizes advanced cultivation techniques, innovative cannabis cultivars, and strategic technology investments to produce premium cannabis products.
 
 
 
 
 In March 2022, TerrAscend completed the acquisition of Gage Growth Corp., a prominent cannabis brand and operator, in a deal valued at over USD 545 million. This strategic acquisition aimed to create a differentiated and compelling player in the North American cannabis market, combining TerrAscend's proven cultivation and manufacturing expertise with Gage's top-selling brands and exceptional retail experiences.
 
 
 
 
 As of January 2023, TerrAscend operated 32 dispensaries nationwide under its award-winning retail concepts, The Apothecarium and Gage. The company's portfolio includes several synergistic businesses and brands, such as Gage Cannabis, Ilera healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. In May 2023, TerrAscend strengthened its balance sheet by selling a facility in Canada for CADUSD 19.7 million, using the proceeds to pay down existing debt.
 
</div>

TerrAscend

Holistic Industries is a multistate cannabis company that specializes in cultivating, manufacturing, and distributing a diverse range of premium cannabis products. Their portfolio includes Liberty Cannabis flower strains, meticulously grown and sustainably cultivated to offer an exceptional experience across indica, sativa, and hybrid varieties. Holistic Industries also produces Strane vape cartridges, crafted with CO2-extracted cannabis oil and all-natural terpenes for a smooth and flavorful vaping experience. Additionally, they offer Strane concentrates in various forms, such as shatter, wax, and live resin, catering to consumers seeking potency and purity. The company's product line further encompasses Holistic Remedies, a collection of topicals and tinctures, as well as elixirs and edibles, including cannabis-infused sparkling waters and chocolates, providing precise dosing and delicious flavors.
Holistic Industries places a strong emphasis on quality control, subjecting their products to rigorous testing processes to ensure they are free from contaminants, pesticides, and consistently meet high standards. The company collaborates with scientists, medical professionals, and researchers to develop cutting-edge cannabis formulations and products. Furthermore, Holistic Industries prioritizes sustainable practices, demonstrating a commitment to environmental responsibility.
In December 2023, Holistic Industries launched the Garcia Hand Picked cannabis brand, a collaboration with the family of Grateful Dead guitarist Jerry Garcia, after years of sampling countless strains to find one worthy of his name.

Holistic Industries

<div>
 
 Flower One is a Nevada-based cannabis cultivator and producer focused on the state's lucrative cannabis market. The company operates a 455,000 square-foot greenhouse and production facility, the largest in Nevada. As of June 2019, Flower One commenced continuous harvest operations, capable of producing 140,000 lbs (62,500 kg) of dry flower annually from over 100,000 plants across eight flower zones per crop cycle. Additionally, Flower One owns North Las Vegas Organics, a 25,000 square-foot indoor cultivation facility with nine grow rooms that can cultivate 4,500 plants per cycle.
 
 
 
 
 Flower One produces a diverse range of cannabis products, including flower, full-spectrum oils, distillates, pre-rolls, concentrates, edibles, and topicals for various brands. In October 2018, the company acquired NLV Organics, a Las Vegas-based cannabis cultivation business, for USD 27 million, expanding its footprint in Nevada's rapidly growing cannabis industry. As of June 2022, Flower One appointed Tim Shoemake as its new Chief Operating Officer, leveraging his over 25 years of experience in global agriculture and food and beverage manufacturing. Flower One trades on the Canadian Securities Exchange under the ticker symbol &quot;FONE&quot;.
 
 
 
</div>

Flower One

Grassroots Cannabis is a vertically integrated multi-state cannabis operator based in Illinois. The company specializes in the cultivation, processing, and retail distribution of medical and recreational cannabis products. Grassroots operates over 20 dispensaries under brands like Herbology, Greenhouse, and Windy City Cannabis across six states, including Illinois, Maryland, Ohio, and Pennsylvania.
The company takes pride in its cultivation process, which involves cloning from mother plants, vegetative growth, flowering, pre-harvest flushing, harvesting, drying, and curing to ensure high-quality cannabis flower, concentrates, vapes, and edibles. Grassroots' product offerings encompass a wide range of strains, both indica and sativa, as well as hybrids. Notable strains include Bubba Diagonal, White OG, Ghost Rider, and Candyland, among others.
In July 2019, Curaleaf, a Massachusetts-based cannabis company, announced plans to acquire Grassroots for USD 875 million in stock and cash. The acquisition expanded Curaleaf's presence from 12 states to 19, adding key markets like Illinois and Pennsylvania to its portfolio. Upon completion of the deal, the combined entity would have 131 dispensary licenses, 68 operational locations, 20 cultivation sites, and 26 processing facilities.

Grassroots Cannabis

Companies that specialize in growing and refining cannabis.

Companies that distribute and sell cannabis and cannabis-related products.

Companies that extract cannabinoids to create cannabis-related medication or edibles.

Companies that carry out medical consultations to prescribe cannabis.

Companies that either provide consultations, educate, or carry out testing of cannabis products.

Some startups employ sustainable farming practices when cultivating cannabis

Sanity Group

Sources

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless